• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Goldline Pharmaceutical Ltd Trading

  • Indian Private
  • BSE Code : 95956.0
  • ISIN : INE1CLW01015
32.49 0 (-0.40%)
  • As on 25 Sep 2026 (EOD)

  • Today’s Low

    32.49

  • Today’s High

    33.75

  • Open

    33.75

  • Perv Close

    32.62

  • 52W Low

    31.62

  • 52W High

    60.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    31.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    25.05

  • Debt-Equity Ratio

    -0.40

  • AGM Date

    25-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    31.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.60

  • BV (₹)

    25.10

  • Sales( ₹ in Cr.)

    31.20

  • NP (in Cr.)

    4.12

  • NP Var(%)

    42.0

  • Div%

    0.0

  • CPS (₹)

    4.50

  • EPS (₹)

    4.30

  • Traded Value (₹ in Lakhs)

    31.19

  • 52 Week High

    60.00

  • 52 Week Low

    31.62

  • Price BSE

    32.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    31.19

  • P/C Ratio

    7.00

  • P/E Ratio

    7.50

  • Price Vs.BV

    4.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 31.20 28.06 23.57 19.85 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 31.20 28.06 23.57 19.85 - -
Other Income 0.00 0.00 0.00 0.00 - -
Stock Adjustments -0.57 -0.71 2.12 -0.09 - -
Total Income 30.63 27.35 25.69 19.76 - -
EXPENDITURE :            
Raw Materials 10.63 10.09 8.19 5.74 - -
Power and Fuel Cost 0.02 0.02 0.02 0.02 - -
Employee Cost 5.71 4.71 4.69 4.63 - -
Other Manufacturing Expenses 0.05 0.04 0.01 0.02 - -
Selling and Administration Expenses 7.16 6.33 8.42 6.93 - -
Miscellaneous Expenses 0.00 0.09 0.04 0.20 - -
Employee Benefit Expenses 5.71 4.71 4.69 4.63 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 23.56 21.29 21.38 17.55 - -
Operating Profit 7.09 6.06 4.30 2.21 - -
Interest 1.46 1.95 1.61 1.63 - -
Gross Profit 5.63 4.11 2.69 0.58 - -
Depreciation 0.24 0.25 0.16 0.18 - -
Profit Before Tax 5.39 3.86 2.53 0.40 - -
Current Tax 1.43 0.99 0.67 0.14 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.17 0.03 0.05 0.01 - -
Reported Net Profit 4.12 2.83 1.81 0.26 - -
Extraordinary Items 0.00 -0.07 -0.03 -0.13 - -
Adjusted Net Profit 4.12 2.90 1.84 0.39 - -
Adjustment below Net Profit 0.09 -3.47 -0.28 -0.65 - -
P & L Balance brought forward 1.55 2.40 2.08 2.48 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.22 0.22 -0.15 0.00 - -
P & L Balance carried down 5.54 1.55 3.76 2.08 - -
Dividend 0.22 0.22 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 5.97 4.11 7.85 1.28 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 18.03 12.25 26.34 20.42 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    57.29%

  • Public Share Holding

    42.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,499,982 57.29 5,499,982 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,499,982 57.29 5,499,982 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 495,000 5.16 495,000 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 750,000 7.81 750,000 39
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,245,000 12.97 1,245,000 54
2] Non Institution
Bodies Corporate 217,000 2.26 217,000 4
Clearing Members 138,000 1.44 138,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,166,000 12.15 1,166,000 6
Individuals holding nominal share capital up to Rs. 1 lakh 1,247,018 12.99 1,247,018 190
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 87,000 0.91 87,000 12
Sub Total 2,855,018 29.74 2,855,018 213
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,600,000 100.00 9,600,000 271

Company Background

Goldline Pharmaceutical LtdTrading

  • Goldline Pharmaceutical Ltd
  • BSE Code : 95956.0
  • ISIN : INE1CLW01015

  • Incorporation Year

    2004

  • Registered Office

    103 F-1 Leela Apartment Shilpa
    HSG Society Shanidham Narendra, Nagpur,
    Maharashtra-440015

  • Telephone

    +91 712 278 6666

  • FAX

  • Chairman

    AMOL LAXMIKANT MUJUMDAR

  • Managing Director

  • Company Secretary

    Ruchi Sanket Modi

  • Auditor

    B Shroff & Co.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Goldline Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Goldline Pharmaceutical 32.49 31.20 31.20 0.00 29.32
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77